DXCM vs GILD
Dexcom vs Gilead Sciences — AI-powered side-by-side comparison
| Metric | DXCM | GILD |
|---|---|---|
| AI Score | 64 | 63 |
| Price | $78.01 | $136.28 |
| P/E Ratio | 32.49× | 18.37× |
| ROE | 0.3% | 0.4% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.6% | 0.8% |
| Debt / Equity | 0.47× | 0.94× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 49.2 | 54.5 |
| Beta | 1.453 | 0.343 |
| Expected Upside | +4.5% | +19.4% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
DXCM Full Analysis
GILD Full Analysis